Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967400 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-BCL2-Associated X Protein (BAX) (AA 43-61) antibody
- Antibody type
- Polyclonal
- Antigen
- Human Bax synthetic peptide
- Description
- Purified from antiserum by negative adsorption and affinity chromatography.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 43-61
- Vial size
- 0.1 mL
- Storage
- 4°C
Submitted references Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma.
Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues.
BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
Bcl-2 and the regulation of programmed cell death.
Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.
Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S, Reed JC
Cancer research 1995 Oct 1;55(19):4471-8
Cancer research 1995 Oct 1;55(19):4471-8
Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues.
Ohta K, Iwai K, Kasahara Y, Taniguchi N, Krajewski S, Reed JC, Miyawaki T
International immunology 1995 Nov;7(11):1817-25
International immunology 1995 Nov;7(11):1817-25
BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
Yin XM, Oltvai ZN, Korsmeyer SJ
Nature 1994 May 26;369(6478):321-3
Nature 1994 May 26;369(6478):321-3
Bcl-2 and the regulation of programmed cell death.
Reed JC
The Journal of cell biology 1994 Jan;124(1-2):1-6
The Journal of cell biology 1994 Jan;124(1-2):1-6
Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.
Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC
The American journal of pathology 1994 Dec;145(6):1323-36
The American journal of pathology 1994 Dec;145(6):1323-36
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.
Oltvai ZN, Milliman CL, Korsmeyer SJ
Cell 1993 Aug 27;74(4):609-19
Cell 1993 Aug 27;74(4):609-19
No comments: Submit comment
No validations: Submit validation data